AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Toxicity and Toxicity Management in Bispecific Antibodies
This chapter discusses the toxicity and management of cytokine release syndrome (CRS) associated with bispecific antibodies in lymphoma, comparing it with CRS after CAR T cells. It explores the variability in CRS rates and manifestations among different bispecific antibodies, and the role of pharmacokinetics, dose, and disease characteristics in CRS occurrence.